{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:48:36Z","timestamp":1775695716032,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12883-014-0247-3","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T17:08:13Z","timestamp":1418749693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Interferon-\u03b2-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab"],"prefix":"10.1186","volume":"14","author":[{"given":"Jens","family":"Harmel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Ringelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Ingwersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mathys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Goebels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Jarius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"247_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005, 202: 473-477. 10.1084\/jem.20050304.","journal-title":"J Exp Med"},{"key":"247_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-10-8","volume":"10","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B: The history of neuromyelitis optica. J Neuroinflamm. 2013, 10: 8-10.1186\/1742-2094-10-8.","journal-title":"J Neuroinflamm"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1468-1331.2009.02897.x","volume":"17","author":"A Uzawa","year":"2010","unstructured":"Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S: Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol. 2010, 17: 672-676. 10.1111\/j.1468-1331.2009.02897.x.","journal-title":"Eur J Neurol"},{"key":"247_CR4","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/archneurol.2010.188","volume":"67","author":"J Palace","year":"2010","unstructured":"Palace J, Leite MI, Nairne A, Vincent A: Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010, 67: 1016-1017. 10.1001\/archneurol.2010.188.","journal-title":"Arch Neurol"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","volume":"75","author":"J Shimizu","year":"2010","unstructured":"Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, Goto J, Shimizu T, Takatsu M, Sakurai Y, Nakase H, Uesaka Y, Hashida H, Hashimoto K, Komiya T, Tsuji S: IFN\u03b2-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010, 75: 1423-1427. 10.1212\/WNL.0b013e3181f8832e.","journal-title":"Neurology"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00415-007-0730-5","volume":"255","author":"Y Shimizu","year":"2008","unstructured":"Shimizu Y, Yokoyama K, Misu T, Takahashi T, Fujihara K, Kikuchi S, Itoyama Y, Iwata M: Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol. 2008, 255: 305-307. 10.1007\/s00415-007-0730-5.","journal-title":"J Neurol"},{"key":"247_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","volume":"291","author":"S Jarius","year":"2010","unstructured":"Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP: Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010, 291: 52-56. 10.1016\/j.jns.2010.01.002.","journal-title":"J Neurol Sci"},{"key":"247_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ana.1096","volume":"50","author":"K Wandinger","year":"2001","unstructured":"Wandinger K, St\u00fcrzebecher C, Bielekova B, Detore G, Rosenwald A, Staudt LM, McFarland HF, Martin R: Complex immunomodulatory effects of interferon-? in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol. 2001, 50: 349-357. 10.1002\/ana.1096.","journal-title":"Ann Neurol"},{"key":"247_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/brain\/awh453","volume":"128","author":"T Ishizu","year":"2005","unstructured":"Ishizu T, Osoegawa M, Mei F, Kikuchi H, Tanaka M, Takakura Y, Minohara M, Murai H, Mihara F, Taniwaki T, Kira J: Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005, 128: 988-1002. 10.1093\/brain\/awh453.","journal-title":"Brain"},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"713519","DOI":"10.1155\/2013\/713519","volume":"2013","author":"N Asgari","year":"2013","unstructured":"Asgari N, Voss A, Steenstrup T, Kyvik KO, Stenager E, Lillevang ST: Interferon alpha association with neuromyelitis optica. Clin Dev Immunol. 2013, 2013: 713519-10.1155\/2013\/713519.","journal-title":"Clin Dev Immunol"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.expneurol.2013.02.005","volume":"247","author":"R Khorooshi","year":"2013","unstructured":"Khorooshi R, Wlodarczyk A, Asgari N, Owens T: Neuromyelitis optica-like pathology is dependent on type I interferon response. Exp Neurol. 2013, 247: 744-747. 10.1016\/j.expneurol.2013.02.005.","journal-title":"Exp Neurol"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1177\/1352458511432896","volume":"18","author":"BM Greenberg","year":"2012","unstructured":"Greenberg BM, Graves D, Remington G, Hardeman P, Mann M, Karandikar N, Stuve O, Monson N, Frohman E: Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success. Mult Scler. 2012, 18: 1022-1026. 10.1177\/1352458511432896.","journal-title":"Mult Scler"},{"key":"247_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jamaneurol.2013.668","volume":"70","author":"BC Kieseier","year":"2013","unstructured":"Kieseier BC, St\u00fcve O, Dehmel T, Goebels N, Leussink VI, Mausberg AK, Ringelstein M, Turowski B, Aktas O, Antoch G, Hartung H: Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses. JAMA Neurol. 2013, 70: 390-393. 10.1001\/jamaneurol.2013.668.","journal-title":"JAMA Neurol"},{"key":"247_CR14","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamaneurol.2013.1246","volume":"70","author":"I Ayzenberg","year":"2013","unstructured":"Ayzenberg I, Kleiter I, Schr\u00f6der A, Hellwig K, Chan A, Yamamura T, Gold R: Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy. JAMA Neurol. 2013, 70: 394-397. 10.1001\/jamaneurol.2013.1246.","journal-title":"JAMA Neurol"},{"key":"247_CR15","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1212\/WNL.0000000000000317","volume":"82","author":"M Araki","year":"2014","unstructured":"Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, Miyake S, Aranami T, Yamamura T: Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology. 2014, 82: 1302-1306. 10.1212\/WNL.0000000000000317.","journal-title":"Neurology"},{"key":"247_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3109\/s10165-012-0715-9","volume":"23","author":"M Araki","year":"2013","unstructured":"Araki M, Aranami T, Matsuoka T, Nakamura M, Miyake S, Yamamura T: Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Mod Rheumatol. 2013, 23: 827-831. 10.3109\/s10165-012-0715-9.","journal-title":"Mod Rheumatol"},{"key":"247_CR17","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1177\/1352458510379247","volume":"16","author":"A Uzawa","year":"2010","unstructured":"Uzawa A, Mori M, Arai K, Sato Y, Hayakawa S, Masuda S, Taniguchi J, Kuwabara S: Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler. 2010, 16: 1443-1452. 10.1177\/1352458510379247.","journal-title":"Mult Scler"},{"key":"247_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/00207450903428970","volume":"120","author":"S I\u00e7\u00f6z","year":"2010","unstructured":"I\u00e7\u00f6z S, T\u00fcz\u00fcn E, K\u00fcrt\u00fcnc\u00fc M, Durmu\u015f H, Mutlu M, Eraksoy M, Akman-Demir G: Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci. 2010, 120: 71-75. 10.3109\/00207450903428970.","journal-title":"Int J Neurosci"},{"key":"247_CR19","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ana.22551","volume":"70","author":"H Zhang","year":"2011","unstructured":"Zhang H, Bennett JL, Verkman AS: Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol. 2011, 70: 943-954. 10.1002\/ana.22551.","journal-title":"Ann Neurol"},{"key":"247_CR20","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1073\/pnas.1017385108","volume":"108","author":"N Chihara","year":"2011","unstructured":"Chihara N, Aranami T, Sato W, Miyazaki Y, Miyake S, Okamoto T, Ogawa M, Toda T, Yamamura T: Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A. 2011, 108: 3701-3706. 10.1073\/pnas.1017385108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"247_CR21","first-page":"1176","volume":"69","author":"MA Mealy","year":"2012","unstructured":"Mealy MA, Wingerchuk DM, Greenberg BM, Levy M: Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol. 2012, 69: 1176-1180.","journal-title":"Arch Neurol"},{"key":"247_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, et al: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflamm. 2012, 9: 14-10.1186\/1742-2094-9-14.","journal-title":"J Neuroinflamm"},{"key":"247_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B: Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci. 2011, 306: 82-90. 10.1016\/j.jns.2011.03.038.","journal-title":"J Neurol Sci"},{"key":"247_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-7-52","volume":"7","author":"S Jarius","year":"2010","unstructured":"Jarius S, Franciotta D, Paul F, Ruprecht K, Bergamaschi R, Rommer PS, Reuss R, Probst C, Kristoferitsch W, Wandinger KP, Wildemann B: Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance. J Neuroinflamm. 2010, 7: 52-10.1186\/1742-2094-7-52.","journal-title":"J Neuroinflamm"},{"key":"247_CR25","first-page":"125","volume":"98","author":"AL Traboulsee","year":"2006","unstructured":"Traboulsee AL, Li DKB: The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol. 2006, 98: 125-146.","journal-title":"Adv Neurol"},{"key":"247_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG: Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006, 63: 390-396. 10.1001\/archneur.63.3.390.","journal-title":"Arch Neurol"},{"key":"247_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2377-13-72","volume":"13","author":"C Cheng","year":"2013","unstructured":"Cheng C, Jiang Y, Chen X, Dai Y, Kang Z, Lu Z, Peng F, Hu X: Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC Neurol. 2013, 13: 72-10.1186\/1471-2377-13-72.","journal-title":"BMC Neurol"},{"key":"247_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2169\/internalmedicine.50.4295","volume":"50","author":"K Ikeda","year":"2011","unstructured":"Ikeda K, Ito H, Hidaka T, Takazawa T, Sekine T, Yoshii Y, Hirayama T, Kawabe K, Kano O, Iwasaki Y: Repeated non-enhancing tumefactive lesions in a patient with a neuromyelitis optica spectrum disorder. Intern Med. 2011, 50: 1061-1064. 10.2169\/internalmedicine.50.4295.","journal-title":"Intern Med"},{"key":"247_CR29","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1191\/1352458505ms1236cr","volume":"11","author":"M Nakamura","year":"2005","unstructured":"Nakamura M, Endo M, Murakami K, Konno H, Fujihara K, Itoyama Y: An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion. Mult Scler. 2005, 11: 735-738. 10.1191\/1352458505ms1236cr.","journal-title":"Mult Scler"},{"key":"247_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6: 805-815. 10.1016\/S1474-4422(07)70216-8.","journal-title":"Lancet Neurol"},{"key":"247_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-013-7169-7","volume":"261","author":"C Trebst","year":"2014","unstructured":"Trebst C, Jarius S, Berthele A, Paul F, Schippling S, Wildemann B, Borisow N, Kleiter I, Aktas O, K\u00fcmpfel T: Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol. 2014, 261: 1-16. 10.1007\/s00415-013-7169-7.","journal-title":"J Neurol"},{"key":"247_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B: AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010, 6: 383-392. 10.1038\/nrneurol.2010.72.","journal-title":"Nat Rev Neurol"},{"key":"247_CR33","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS: Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol. 2014, 10: 493-506. 10.1038\/nrneurol.2014.141.","journal-title":"Nat Rev Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-014-0247-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0247-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-014-0247-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:56:19Z","timestamp":1630565779000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-014-0247-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1186\/s12883-014-0247-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"27 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"247"}}